quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:21:08·665d
NEWSRelease
Protagonist Therapeutics Inc. logo
Encore Wire Corporation logo

Protagonist Therapeutics To Join S&P SmallCap 600, Effective Prior To Opening Of Trading On July 3

PTGX· Protagonist Therapeutics Inc.WIRE· Encore Wire Corporation
Health CareIndustrials
Original source

Companies

  • PTGX
    Protagonist Therapeutics Inc.
    Health Care
  • WIRE
    Encore Wire Corporation
    Industrials

Recent analyst ratings

  • Sep 17PTGXUpdateBarclays$72.00
  • Sep 12PTGXUpdateLeerink Partners$73.00
  • Jun 17PTGXUpdateCitigroup$72.00
  • Dec 6PTGXUpdateGoldman$47.00
  • Dec 6PTGXUpdateBMO Capital Markets$62.00
  • Nov 5PTGXUpdateWedbush$58.00

Related

  • INSIDER2d
    SEC Form 4 filed by Ali Asif
  • NEWS7d
    Protagonist Therapeutics Reports Granting of Inducement Awards
  • NEWS26d
    Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting
  • INSIDER27d
    SEC Form 4 filed by Molina Arturo Md
  • INSIDER27d
    SEC Form 4 filed by Selick Harold E
  • INSIDER27d
    SEC Form 4 filed by Ali Asif
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Protagonist Therapeutics Inc.
  • SEC28d
    SEC Form 144 filed by Protagonist Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022